Navigation Links
Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
Date:9/22/2008

Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today launched BioNuesisTM, the only soluble human extracellular matrix (ECM) developed as a culturing kit for stem cell growth. The kit was launched and is being exhibited at the 2008 World Stem Cell Summit taking place in Madison, Wisconsin.

San Diego, CA (PRWEB) September 22, 2008 -- Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today launched BioNuesisTM, the only soluble human extracellular matrix (ECM) developed as a culturing kit for stem cell growth. The kit was launched and is being exhibited at the 2008 World Stem Cell Summit taking place in Madison, Wisconsin.

Through its proprietary bioreactors, Histogen is uniquely capable of simulating the embryonic environment, creating products that are embryonic-like in nature without the utilization of embryonic stem cells. Products are developed by extracting the proteins and growth factors produced by these fibroblasts. In working with the unique liquid formulation, Histogen researchers identified the potential for the human soluble ECM in the field of stem cell research, as compared to currently available products.

"There is a significant need for an all-human ECM product that can support pluripotent huES cell expansion in culture, without the complications inherent with mouse tumor-derived ECM extracts that are still the best replacement for feeder-layer cells," Dr. Jeanne Loring, Director of the Center for Regenerative Medicine at Scripps Research Institute. "Histogen's technology may provide the solution and help accelerate both basic science and translational research using huES cells."

BioNuesis is the first product that provides a limitless source of the natural human ECM proteins, such as laminin, coll
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
(Date:11/6/2009).... 6 BioSpecifics Technol...company developing first-in-class collagenase-base...for the third quarter ended September 30, 2009. ,...f this year, the FDA,s Arthritis Advisory Committe...approval of XIAFLEX(TM) for the treatment of Dupuy...
(Date:11/6/2009)..., November 6 EUCODIS Bioscience, a...nd marketing enzymes for the,chemical industry ann...greement with Bio Sidus, the leading biopharmaceut...ement gives EUCODIS Bioscience exclusive access - ...us, proprietary collection of,psychrophilic bacter...
(Date:11/6/2009)...Newswire-FirstCall/ - Oncolytics Biotech Inc. (TSX... today announced updated results from a Phase II s...arcomas metastatic to the lung in a poster present...y Society Meeting held in Miami Beach, Florida, fr...ntitled "A Phase II Study of Intravenous REOLYSIN ...
(Date:11/5/2009)...ne hybrid . . . , Fuel economy ratings for the... the www.fueleconomy.gov web site, which Oak Rid... the U.S. Department of Energy and the U.S. Enviro...cles on the best fuel economy list are hybrid elec...ghway). "This list proves that hybrids have gone m...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...NAPOLIS, and CAMBRIDGE, Mass., May 5 Amylin Pha...nd Company (NYSE: LLY ) and Alkermes, Inc. (Nasd...cation (NDA) for exenatide once weekly has been su...FDA). Exenatide once weekly is an investigational ...hat is injected subcutaneously and administered on...
...SCO, Calif., May 5 Rigel Pharmaceuticals, Inc. (N...or the first quarter ended March 31, 2009. , , Fo...loss of $29.9 million, or $0.82 per share, compare...re, in the first quarter of 2008. Weighted average... and 2008 were 36.7 million and 34.4 million, resp...
...hallenges separate haves and have-nots and acceler... Despite worldwide economic turmoil, the global b...performance in 2008, according to Beyond borders:...ung,s 23rd annual report on the biotech industry. ...t is placing the business model that fueled biotec...
Other Biology Technology:Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 2Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 3Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 4Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 5Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 6Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 7Rigel Announces First Quarter 2009 Financial Results 2Rigel Announces First Quarter 2009 Financial Results 3Rigel Announces First Quarter 2009 Financial Results 4Rigel Announces First Quarter 2009 Financial Results 5Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 2Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 3Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 4
(Date:11/9/2009)...ELPHIA, NOVEMBER 9, 2009 A nutritionist whose re...ables to the federal Women, Infants and Children (...Agnes Higgins Award for outstanding achievement in... Harrison, Ph.D., MNS, , a professor in the Depart...y of California, Los Angeles School of Public Heal...
(Date:11/8/2009)...STON - (Nov. 8, 2009) The loss of a gene through ...ssociated with significant abnormalities in learni...led by Baylor College of Medicine ( www.bcm.edu ) ...al Nature Genetics . , "This research goes abou...in a specific group of individuals to this gene," ...
(Date:11/6/2009)...X, Va.Registration is now open for the Society of ...ional Oncology (IO) Therapies" Webinar, which will...anscatheter treatment of liver tumors, kidney tumo...nal organization of physicians, scientists and all...blic health through pioneering advances in image-g...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Developmental delay could stem from nicotinic receptor deletion 2Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 1Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 3Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 4Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 1Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 2Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 3Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 4Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 1Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 2Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 3
...ce penicillin, a byproduct of a fungal mold, was d...gi for other breakthrough drugs. As reported Jan....m led by a University of Wisconsin-Madison researc...ongoing quest for medically useful compounds in fu...the team, led by professor of plant pathology and ...
...ence is emerging that climate change could reduce ...lso international efforts to cut poverty. However,...dy providing researchers with some of the tools th...oid the worst effects of the problem. , The new kn...wing scientists to both develop new rice varieties...
... 2005 may have been the warmest year in a century,... data from around the world. , Climatologists at N...n New York City noted that the highest global annu...ury was recorded in their analysis for the 2005 ca...udy climate change rank 2005 as the second warmest...
Other Biology News:Mining for gems in the fungal genome 2Mining for gems in the fungal genome 3Climate change: The rice genome to the rescue 2Climate change: The rice genome to the rescue 32005 was the warmest year in a century 2
iEMS thermal microplate holder from Thermo Scientific
Deluxe CO2 Backup, Factory Installed, All Voltages, for 3.0 and 6.7 cu ft -86C Chest Freezers & all -40C/ -86C Upright Freezers from Thermo Scientific
LN2 Backup, Factory Installed, All Voltages, for 3.0 and 6.7 cu ft -86C Chest Freezers & all -40C/ -86C Upright Freezers from Thermo Scientific
...se H- Reverse Transcriptase (RT) is an improved ve... a DNA polymerase that synthesizes a complementary...:DNA hybrid. This enzyme is genetically engineered...n a deletion in the RNase H active center. Like Su...
Biology Products: